Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell Migration

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.

Cytoskeletal Coordination in Cell Migration

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of Adult T-Cell Leukemia/Lymphoma During Treatment with PD-L1 Inhibitor for Lung Cancer.

Internal medicine (Tokyo, Japan)·2025

Same author

Reduction in the need for surgery and mortality after early administration of fibrinolytics following empyema drainage.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024

Same author

A Japanese herbal medicine (kampo), hochuekkito (TJ-41), has anti-inflammatory effects on the chronic obstructive pulmonary disease mouse model.

Scientific reports·2024

Same author

Efficacy of initial high- versus low-dose intravenous corticosteroid therapy in patients with acute exacerbation of idiopathic interstitial pneumonia: A nationwide observational study.

Annals of clinical epidemiology·2024

Same author

Relationship between serum IgA levels and low percentage forced expiratory volume in the first second in asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·2024

Same author

Anti-Inflammatory Effects of Japanese Herbal Medicine Hochuekkito in a Mouse Model of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Pharmacology·2024

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Procaterol inhibits lung fibroblast migration.

Tadashi Kohyama¹, Yasuhiro Yamauchi, Hajime Takizawa

¹Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. koyama-tky@umin.ac.jp

|September 4, 2009

Summary

Procaterol, a beta (2)-agonist, effectively inhibited human fetal lung fibroblast migration, a key process in lung fibrosis. This suggests procaterol may be a potential therapeutic for lung injury and fibrosis.

Related Experiment Videos

Last Updated: Jun 20, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Area of Science:

Pulmonary Medicine
Cell Biology
Pharmacology

Background:

Fibroblast migration contributes to lung fibrosis and chronic obstructive pulmonary disease pathogenesis.
Uncontrolled inflammation can lead to excess fibroblast accumulation around small airways.

Purpose of the Study:

To investigate the effect of procaterol, a beta (2)-agonist, on human fetal lung fibroblast (HFL-1) migration.
To explore the underlying mechanism of procaterol's effect on fibroblast migration.

Main Methods:

Utilized the blindwell chamber technique to assess HFL-1 migration induced by human plasma fibronectin (HFn).
Investigated the role of beta (2)-receptors, beta (1)-receptors, and the cyclic AMP-dependent protein kinase (PKA) pathway using specific inhibitors (ICI 181551, atenolol, KT5720).

Main Results:

Procaterol (10(-8) M) significantly inhibited HFL-1 migration by approximately 27% (p < 0.05).
The inhibitory effect was concentration-dependent and mediated via beta (2)-receptors.
The cyclic AMP-PKA pathway was implicated in the procaterol-induced inhibition of fibroblast migration.

Conclusions:

Procaterol demonstrates potential as a therapeutic agent for inhibiting lung fibrosis.
The findings suggest procaterol's utility in managing lung injuries characterized by fibrosis.